News Archives

News Archives

Avivagen Retains ITG to Conduct Market Making Activities

Ottawa, ON / TNW-Accesswire / October 2, 2018 /– Avivagen Inc. (TSXV:VIV) (“Avivagen), is pleased to announce that it has retained the services of Independent Trading Group (“ITG”) to conduct Market Making activities. ITG will trade shares of Avivagen on the TSX Venture Exchange with the objective of maintaining a reasonable market and improving the liquidity …Read More

Avivagen Announces First Order for OxC-beta™ Livestock in Thailand

Ottawa, ON / TNW-Accesswire / September 26, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”),is pleased to announce that it has received its first order for OxC-beta™ Livestock in Thailand.  The 100kg order also represents the first time OxC-beta™ Livestock will be used for commercial application in sow feeds.    Use in sow feeds, which is …Read More

Avivagen Announces its Attendance at BIOSPAIN 2018

Ottawa, ON / TNW-Accesswire / September 24, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen), is pleased to announce that it will be attending BIOSPAIN 2018, in Seville, Spain, from September 25th-27th, 2018. Avivagen was invited to attend by the Department of Foreign Affairs, Trade & Development, Canada (DFATD) and is representing Canada with Mr. Kym …Read More

Avivagen Announces Follow-On Large Order from UNAHCO for OxC-beta™ Livestock

Ottawa, ON / TNW-Accesswire / September 20, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences Corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that its partner in the Philippines, …Read More

Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Ottawa, ON – September 17, 2018 — Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products …Read More

Avivagen Announces Q3 Financial Results and Proposed Extension of Warrants

Ottawa, ON / TNW-Accesswire / September 5, 2018 / – – Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, today reported its financial results for Q3, 2018.  Unless otherwise …Read More